Literature DB >> 19137282

Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.

R B J de Bondt1, M C Hoeberigs, P J Nelemans, W M L L G Deserno, C Peutz-Kootstra, B Kremer, R G H Beets-Tan.   

Abstract

INTRODUCTION: The aim was to determine the diagnostic accuracy and additional value of diffusion-weighted imaging for detection of malignant lymph nodes in head and neck squamous cell carcinoma.
METHODS: Two hundred nineteen lymph nodes, predominantly smaller than 10 mm (95.4%), in 16 consecutive patients were evaluated at 1.5 T. Lymph nodes were evaluated for maximum short axial diameter, morphological criteria, and apparent diffusion coefficient (ADC) values (b = 0 and b = 1,000 s/mm(2)). Sensitivity, specificity, positive and negative predictive values as well as diagnostic odds ratios (DORs) and areas under the curves (AUCs) of ROC curves were calculated for the various magnetic resonance imaging (MRI) criteria individually and in combination. Histological examination of lymph nodes in the neck dissection specimen was the gold standard to determine malignant involvement.
RESULTS: The optimal ADC threshold was 1.0 x 10(-3) mm(2)/s. Using this cutoff point, sensitivity and specificity were 92.3% and 83.9%, respectively. When used in combination with size and morphological criteria, ADC value <1.0 x 10(-3) mm(2)/s was the strongest predictor of presence of metastasis (DOR = 97.6). A model which added ADC values to the other MRI criteria performed significantly better than a model without ADC values: AUC = 0.98 versus AUC = 0.91 (p = 0.036).
CONCLUSION: In this study, with predominantly small lymph nodes, the ADC criterion is the strongest independent predictor of presence of metastasis. The use of ADC values in combination with the other MRI criteria significantly improves the discrimination between malignant and benign lymph nodes.

Entities:  

Mesh:

Year:  2009        PMID: 19137282     DOI: 10.1007/s00234-008-0487-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  32 in total

1.  Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings.

Authors:  Vincent Vandecaveye; Frederik De Keyzer; Sandra Nuyts; Karen Deraedt; Piet Dirix; Pascal Hamaekers; Vincent Vander Poorten; Pierre Delaere; Robert Hermans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-04       Impact factor: 7.038

2.  Time-dose factors in positive neck nodes treated with irradiation only.

Authors:  J M Taylor; W M Mendenhall; R S Lavey
Journal:  Radiother Oncol       Date:  1991-11       Impact factor: 6.280

3.  Comparison of CT and MR imaging in staging of neck metastases.

Authors:  H D Curtin; H Ishwaran; A A Mancuso; R W Dalley; D J Caudry; B J McNeil
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

4.  Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases.

Authors:  V Vandecaveye; F de Keyzer; V Vander Poorten; K Deraedt; H Alaerts; W Landuyt; S Nuyts; R Hermans
Journal:  Br J Radiol       Date:  2006-04-26       Impact factor: 3.039

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

6.  Role of diffusion weighted MR in the discrimination diagnosis of the cystic and/or necrotic head and neck lesions.

Authors:  Osman Koç; Yahya Paksoy; Ibrahim Erayman; Ali Sami Kivrak; Hamdi Arbag
Journal:  Eur J Radiol       Date:  2006-12-22       Impact factor: 3.528

7.  Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging.

Authors:  J Wang; S Takashima; F Takayama; S Kawakami; A Saito; T Matsushita; M Momose; T Ishiyama
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

8.  [Effect of various forms of metastatic lymph node involvement on prognosis of squamous epithelial carcinomas of the upper aerodigestive tract].

Authors:  W Kehrl; S Wenzel; A Niendorf
Journal:  Laryngorhinootologie       Date:  1998-10       Impact factor: 1.057

9.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug

10.  [Neck lymph node dissection in squamous cell carcinoma originating in the head-and-neck area; the significance for the prognosis].

Authors:  C R Leemans; R M Tiwari; I van der Waal; A B Karim; J J Nauta; G B Snow
Journal:  Ned Tijdschr Geneeskd       Date:  1992-02-01
View more
  31 in total

Review 1.  Biologic imaging of head and neck cancer: the present and the future.

Authors:  A Srinivasan; S Mohan; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

2.  Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response.

Authors:  Ann D King; Frankie K F Mo; Kwok-Hung Yu; David K W Yeung; Hua Zhou; Kunwar S Bhatia; Gary M K Tse; Alexander C Vlantis; Jeffrey K T Wong; Anil T Ahuja
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

3.  Differential diagnosis of axillary inflammatory and metastatic lymph nodes in rabbit models by using diffusion-weighted imaging: compared with conventional magnetic resonance imaging.

Authors:  Junping Wang; Qian Liao; Yunting Zhang; Chunshui Yu; Renju Bai; Haoran Sun
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

4.  Intravoxel incoherent motion MR imaging: comparison of diffusion and perfusion characteristics between nasopharyngeal carcinoma and post-chemoradiation fibrosis.

Authors:  Vincent Lai; Xiao Li; Victor Ho Fun Lee; Ka On Lam; Queenie Chan; Pek Lan Khong
Journal:  Eur Radiol       Date:  2013-05-31       Impact factor: 5.315

5.  Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: a pilot study.

Authors:  J Si; S Huang; H Shi; Z Liu; Q Hu; G Wang; G Shen; D Zhang
Journal:  Dentomaxillofac Radiol       Date:  2014-01-22       Impact factor: 2.419

Review 6.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

7.  High-resolution diffusion-weighted imaging of neck lymph nodes using 2D-single-shot interleaved multiple inner volume imaging diffusion-weighted echo-planar imaging at 3T.

Authors:  J K Park; S-E Kim; G S Trieman; D Parker; E-K Jeong
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-09       Impact factor: 3.825

8.  Differentiation of lymphomatous, metastatic, and non-malignant lymphadenopathy in the neck with quantitative diffusion-weighted imaging: systematic review and meta-analysis.

Authors:  Seyedmehdi Payabvash; Alexandria Brackett; Reza Forghani; Ajay Malhotra
Journal:  Neuroradiology       Date:  2019-06-07       Impact factor: 2.804

9.  Discrimination and anatomical mapping of PET-positive lesions: comparison of CT attenuation-corrected PET images with coregistered MR and CT images in the abdomen.

Authors:  Felix P Kuhn; David W Crook; Caecilia E Mader; Philippe Appenzeller; G K von Schulthess; Daniel T Schmid
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-07       Impact factor: 9.236

Review 10.  PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine.

Authors:  Patrick Veit-Haibach; Felix Pierre Kuhn; Florian Wiesinger; Gaspar Delso; Gustav von Schulthess
Journal:  MAGMA       Date:  2012-10-09       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.